Volume 17, Number 6—June 2011
Research
Methicillin-Resistant Staphylococcus aureus, Samoa, 2007–2008
James Alesana-Slater, Stephen R. Ritchie
, Helen Heffernan, Tracy Camp, Alice Richardson, Peter Herbison, and Pauline Norris
, Helen Heffernan, Tracy Camp, Alice Richardson, Peter Herbison, and Pauline Norris
Table 1
Demographic characteristics of study participants and prevalence of MSSA and MRSA, Samoa, summer 2007–2008*
| Characteristic | Total study population | No. (%, 95% CI) |
||
|---|---|---|---|---|
| S. aureus positive | MSSA | MRSA | ||
| No. participants |
399 |
187 (47, 42–52) |
153 (38, 34–43) |
34 (9, 6–12) |
| Male sex |
263 |
121 (46, 40–52) |
95 (36, 31–42) |
26 (10, 7–14) |
| Age, y† | ||||
| <5 | 53 | 37 (70, 56–81)‡ | 33 (62, 49–74) | 4 (8, 3–18) |
| 5–15 | 93 | 50 (54, 44–64) | 44 (47, 38–57) | 6 (7, 3–14) |
| 16–59 | 195 | 79 (34–48) | 60 (31, 25–38) | 19 (10, 6–15) |
| >60 |
58 |
21 (36, 25–49) |
16 (28, 18–40) |
5 (9, 3–19) |
| Antimicrobial drug treatment in previous month | 224 | 84 (38, 31–44)§ | 67 (30, 24–36) | 17 (8, 5–12) |
| Health care contact in previous 3 months | 262 | 108 (41, 35–47) | 85 (32, 27–38) | 23 (9, 6–13) |
*MSSA, methicillin-susceptible Staphylococcus aureus, MRSA, methicillin-resistant S. aureus; CI, confidence interval.
†Median age, y (range) of study participants: All, 32 (0–89); S. aureus positive, 24 (0–84); MSSA positive, 26 (0–84); MRSA positive, 36 (0–76).
‡p<0.001, S. aureus positive vs. study population >5 y of age.
§p<0.001, S. aureus positive vs. no antimicrobial drug treatment in the previous month.
Page created: August 03, 2011
Page updated: August 03, 2011
Page reviewed: August 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.